Filing Details

Accession Number:
0001415889-18-000453
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-29 17:03:22
Reporting Period:
2018-03-27
Accepted Time:
2018-03-29 17:03:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1437237 Jr L Frank Jaksch 10005 Muirlands Blvd.
Suite G
Irvine CA 92618
Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-27 24,578 $4.50 226,135 No 4 M Direct
Common Stock Disposition 2018-03-27 24,578 $4.60 201,557 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Options (right to buy) Disposition 2018-03-27 24,578 $0.00 24,578 $4.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
171,977 2009-04-21 2018-04-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,075,052 Indirect By Black Sheep, FLP
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on March 16, 2018. The options exercised and sold were scheduled to expire on April 21, 2018.